News
Scientists enhance eye imaging with AI, achieving high-resolution views of retinal cells, potentially revolutionizing disease ...
Chengdu Origen Biotechnology Co, Ltd. And Vanotech Ltd. recently announced the dosing of the first patient in the VAN-2401 multi-center phase 1 clinical trial (NCT06825858). 1 The VAN-2401 clinical ...
By isolating and focusing on stimulating only the M cells on the retina, they created a new color signal that the human eye ...
The OcuMet Beacon is a proprietary, noninvasive tool for assessing retinal health. The company said it will be available on the US market for use in clinics and healthcare institutions. The US Food ...
A panelist discusses how a man aged 79 years with long-duration diabetes and treatment-naive diabetic macular edema (DME) responded well to aflibercept 8-mg therapy, progressing from 4-week loading ...
Lukas Scheibler, PhD, has been appointed as chief research and development officer and Graham Cooper as chief financial officer of Tavo Biotherapeutics, the company recently announced. 1 “I am ...
The 2025 Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting will take place May 4-8, 2025, in Salt Lake City, Utah. This meeting will feature presenter and researcher from ...
A panelist discusses how a woman aged 77 years with bilateral neovascular age-related macular degeneration (nAMD) demonstrated different responses to treatments between her eyes, showing a superior ...
Prevent Blindness has declared May the second annual inherited retinal disease and genetic testing month, offering free resources on education and other awareness efforts. Offering a variety of free ...
Regression analysis identified significant associations between the polygenic risk scores for schizophrenia, pathway-specific scores, and specific retinal layers, 1 according to coauthors Finn Rabe, ...
Retina World Congress 2025 is set to take place in Fort Lauderdale, Florida on May 8 through May 11, 2025. This meeting brings together retina specialists from around the globe to discuss research ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results